ArticleAdvances in therapy2022

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart

Peter Rieckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.